Company Filing History:
6 out of 1,588 
3 out of 973 
1 out of 20 Years Active: 1990-2010
Title: **Yoh-Ichi Matsumoto: Innovator in Biopharmaceuticals**
Introduction
Yoh-Ichi Matsumoto is a distinguished inventor based in Tokyo, Japan, renowned for his significant contributions to the fields of biopharmaceuticals and immunology. With a remarkable portfolio of six patents, Matsumoto has played a crucial role in the development of cutting-edge therapies and diagnostic tools, particularly in combating infectious diseases.
Latest Patents
Among Matsumoto's latest inventions are groundbreaking humanized antibodies designed to recognize Verotoxin II, which are vital for treating patients suffering from the toxic effects of this potent toxin. Additionally, he has developed human monoclonal antibodies specific for HIV, aimed at offering new avenues for the diagnosis, prevention, and therapy of HIV infection. His innovative approaches highlight the ongoing need for advancements in medical science.
Career Highlights
Yoh-Ichi Matsumoto has garnered extensive experience through his professional endeavors. He has collaborated with prestigious organizations such as Teijin Limited and the University of Arizona, where he has furthered his research and contributions to the field. His work has not only enriched his own knowledge but has also propelled the advancement of treatments that are critical in addressing complex health challenges.
Collaborations
Throughout his career, Matsumoto has worked closely with notable colleagues, including Yasuhiko Masuho and Toru Sugano. Their joint efforts have led to significant advancements in the understanding and treatment of various diseases, demonstrating the power of collaboration in fostering innovation.
Conclusion
Yoh-Ichi Matsumoto's innovative spirit and dedication to improving healthcare outcomes through his inventions are commendable. His six patents exemplify the impact that dedicated inventors can have in addressing pressing global health issues. As he continues his work in Tokyo, the contributions of Matsumoto are sure to influence future developments in biopharmaceuticals and beyond.